HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (2) Citing Articles via Google Scholar Google Scholar Articles by Luo, L. Articles by Luo, J. Z. Q. Search for Related Content PubMed PubMed Citation Articles by Luo, L. Articles by Luo, J. Z. Q.

The molecular mechanism of EGF receptor activation in pancreatic -cells by thyrotropin-releasing hormone

¹The Center of Stem Cell Biology, Department of Research, Roger Williams Hospital; ²Pediatrics, Women and Infants Hospital; and ³Program in Liberal Medical Education, Brown University, Providence, Rhode Island

Submitted 23 September 2005 ; accepted in final form 6 December 2005

Thyrotropin-releasing hormone (TRH) and its receptor subtype TRH receptor-1 (TRHR1) are found in pancreatic -cells, and it has been shown that TRH might have potential for autocrine/paracrine regulation through the TRHR1 receptor. In this paper, TRHR1 is studied to find whether it can initiate multiple signal transduction pathways to activate the epidermal growth factor (EGF) receptor in pancreatic -cells. By initiating TRHR1 G protein-coupled receptor (GPCR) and dissociated -complex, TRH (200 nM) activates tyrosine residues at Tyr⁸⁴⁵ (a known target for Src) and Tyr¹⁰⁶⁸ in the EGF receptor complex of an immortalized mouse -cell line, TC-6. Through manipulating the activation of Src, PKC, and heparin-binding EGF-like growth factor (HB-EGF), with corresponding individual inhibitors and activators, multiple signal transduction pathways linking TRH to EGF receptors in TC-6 cell line have been revealed. The pathways include the activation of Src kinase and the release of HB-EGF as a consequence of matrix metalloproteinase (MMP)-3 activation. Alternatively, TRH inhibited PKC activity by reducing the EGF receptor serine/threonine phosphorylation, thereby enhancing tyrosine phosphorylation. TRH receptor activation of Src may have a central role in mediating the effects of TRH on the EGF receptor. The activation of the EGF receptor by TRH in multiple circumstances may have important implications for pancreatic -cell biology.

heparin-binding epidermal growth factor-like growth factor; Src; protein kinase C; G protein; signal transduction

This article has been cited by other articles:

				A. C. Snider and K. E. Meier Receptor transactivation cascades. Focus on "Effects of {alpha}1D-adrenergic receptors on shedding of biologically active EGF in freshly isolated lacrimal gland epithelial cells" Am J Physiol Cell Physiol, January 1, 2007; 292(1): C1 - C3. [Full Text] [PDF]

				N. Yamamoto, G. Mammadova, R. X.-D. Song, Y. Fukami, and K.-i. Sato Tyrosine phosphorylation of p145met mediated by EGFR and Src is required for serum-independent survival of human bladder carcinoma cells J. Cell Sci., November 15, 2006; 119(22): 4623 - 4633. [Abstract] [Full Text] [PDF]